drugset / Trial / NCT07071714
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-8068 injection in combination with anti-tumor therapies in subjects with colorectal cancer.
Timeline
- Start
- 2025-07-22
- Primary completion
- 2031-10
- Completion
- 2031-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | — | — |
| Subject | SHR-8068 | Monoclonal antibody | — | — |
| Background | Adebrelimab | Monoclonal antibody | — | — |